Jolanta Klukowska-Roetzler

Dr. Jolanta Klukowska-Roetzler

orcid

Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 March 2020 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
Michael DoulberisMichael Doulberis
Michael Doulberis
SSSimone Srivastava
Simone Srivastava
SPStergios A Polyzos
Stergios A Polyzos
JKJannis Kountouras
Jannis Kountouras
APApostolis Papaefthymiou
Apostolis Papaefthymiou
David Shiva  SrivastavaDavid Shiva Srivastava
David Shiva Srivastava
Nonalcoholic fatty liver disease (NAFLD) emerges as an important global burden and Helicobacter pylori infection (Hp-I) has been suggested as a risk factor of NAFLD, although controversy exists. This retrospective study aimed to investigate a potential impact of active Hp-I on NAFLD severity in morbidly obese patients, subjected to bariatric surgery and gastric biopsy for documentation of Hp-I. Of 64 eligible participants, 15 (23.4%) were diagnosed with active Hp-I, showing higher rates of nonalcoholic steatohepatitis (NASH) than those without Hp-I (86.7% vs. 26.5%, respectively; p < 0.001). Concerning histological lesions, steatosis grade (p = 0.027), ballooning (p < 0.001), lobular inflammation (p = 0.003), and fibrosis stage (p < 0.001) were also more severe in Hp-I positive patients. Likewise, liver function tests, insulin resistance, dyslipidemia, and arterial hypertension were significantly higher in Hp-I positive patients. Hp-I was independently positively associated with NASH (beta = 3.27; p = 0.002), severe NASH (beta = 2.37; p = 0.018), and the presence of fibrosis (beta = 3.86; p = 0.001) in a binary regression model, after adjustment for potential confounders. In conclusion, active Hp-Ι was independently associated with NASH and fibrosis, findings offering potential clinical implication.

1 May 2007 in Equine Veterinary Journal
Verified
Journal Article
Closed access
PDF file
UJU. Jost
U. Jost
JKJolanta Klukowska-Roetzler
Jolanta Klukowska-Roetzler
GDG. Dolf
G. Dolf
JSJ. E. Swinburne
J. E. Swinburne
ARA. Ramseyer
A. Ramseyer
VGV. Gerber
V. Gerber

Michael MatsangosMichael Matsangos
Michael Matsangos
LZLaoura Ziaka
Laoura Ziaka
Aristomenis  Exadaktylos Aristomenis Exadaktylos
Aristomenis Exadaktylos
JKJolanta Klukowska-Roetzler
Jolanta Klukowska-Roetzler
MZMairi Ziaka
Mairi Ziaka
Four decades of civil war, violence, and destabilisation have forced millions of Afghans to flee their homes and to move to other countries worldwide. This increasing phenomenon may challenge physicians unfamiliar with the health status of this population, which may be markedly different from that of the host country. Moreover, several factors during their migration, such as transport in closed containers, accidental injuries, malnutrition, and accommodation in detention centres and refugee camps have a major influence on the health of refugees. By taking into account the variety of the specific diseases among migrant groups, the diversity of the origins of refugees and asylum seekers, and the increasing numbers of Afghan refugees, in this review we focus on the population of Afghans and describe their health status with the aim of optimising our medical approach and management. Our literature review shows that the most prevalent reported infections are tuberculosis and other respiratory tract infections and parasitic diseases, for example leishmaniasis, malaria, and intestinal parasitic infections. Anaemia, hyperlipidaemia, arterial hypertension, diabetes, smoking, overweight, malnutrition, low socioeconomic status, and poor access to healthcare facilities are additional risk factors for non-communicable diseases among Afghan refugees. With regards mental health issues, depression and post-traumatic stress disorder (PTSD) are the most common diagnoses and culture shock and the feeling of being uprooted modulate their persistence. Further research is needed in order to provide us with extensive, high-quality data about the health status of Afghan refugees. The main objective of this review is to identify protective factors which could ensure key health concepts and good clinical practice.

KHKatrin Henke
Katrin Henke
SNSotirios Ntovas
Sotirios Ntovas
EXEleni Xourgia
Eleni Xourgia
Aristomenis  Exadaktylos Aristomenis Exadaktylos
Aristomenis Exadaktylos
JKJolanta Klukowska-Roetzler
Jolanta Klukowska-Roetzler
MZMairi Ziaka
Mairi Ziaka
Toxocariasis remains an important neglected parasitic infection representing one of the most common zoonotic infections caused by the parasite Toxocara canis or, less frequently, by Toxocara cati. The epidemiology of the disease is complex due to its transmission route by accidental ingestion of embryonated Toxocara eggs or larvae from tissues from domestic or wild paratenic hosts. Even though the World Health Organization and Centers for Disease Control classified toxocariasis amongst the top six parasitic infections of priority to public health, global epidemiological data regarding the relationship between seropositivity and toxocariasis is limited. Although the vast majority of the infected individuals remain asymptomatic or experience a mild disease, the infection is associated with important health and socioeconomic consequences, particularly in underprivileged, tropical, and subtropical areas. Toxocariasis is a disease with multiple clinical presentations, which are classified into five distinct forms: the classical visceral larva migrans, ocular toxocariasis, common toxocariasis, covert toxocariasis, and cerebral toxocariasis or neurotoxocariasis. Anthelmintic agents, for example, albendazole or mebendazole, are the recommended treatment, whereas a combination with topical or systemic corticosteroids for specific forms is suggested. Prevention strategies include educational programs, behavioral and hygienic changes, enhancement of the role of veterinarians, and anthelmintic regimens to control active infections.

SKSarah A. Keller
Sarah A. Keller
JKJolanta Klukowska-Roetzler
Jolanta Klukowska-Roetzler
KSKatharina M. Schenk-Jaeger
Katharina M. Schenk-Jaeger
HKHugo Kupferschmidt
Hugo Kupferschmidt
Aristomenis  Exadaktylos Aristomenis Exadaktylos
Aristomenis Exadaktylos
ELEvangelia Liakoni
Evangelia Liakoni
The consequences of mushroom poisoning range from mild, mostly gastrointestinal, disturbances to organ failure or even death. This retrospective study describes presentations related to mushroom poisoning at an emergency department in Bern (Switzerland) from January 2001 to October 2017. Gastrointestinal disturbances were reported in 86% of the 51 cases. The National Poisons Information Centre and mycologists were involved in 69% and 61% of the cases, respectively. Identification of the mushroom type/family was possible in 43% of the cases. The most common mushroom family was Boletaceae (n = 21) and the most common mushrooms Xerocomus chrysenteron (n = 7; four being part of a cluster), Clitocybe nebularis, Lepista nuda and Lactarius semisanguifluus (n = 5 each, four being part of a cluster). Poisonous mushrooms included Amanita phalloides (n = 3, all analytically confirmed), Boletus satanas (n = 3), Amanita muscaria (n = 2) and Amanita pantherina (n = 2). There were no fatalities and 80% of the patients were discharged within 24 h. Mushroom poisoning does not appear to be a common reason for emergency consultation and most presentations were of minor severity and related to edible species (e.g., due to incorrect processing). Nevertheless, poisonous mushrooms and severe complications were also recorded. Collaboration with a poison centre and/or mycologists is of great importance, especially in high risk cases.

1 May 2007 in Gene
Verified
Journal Article
Closed access
ASAnna Skorczyk-Werner
Anna Skorczyk-Werner
MSMonika Stachowiak
Monika Stachowiak
ISIzabela Maria Szczerbal
Izabela Maria Szczerbal
JKJolanta Klukowska-Roetzler
Jolanta Klukowska-Roetzler
CSClaude Pierre Schelling
Claude Pierre Schelling
MSMarek Switonski
Marek Switonski